Cardiovascular News Issue 23 – November 2011

5924

Highlights:
-Lower thrombosis risk with newer generation drug-eluting stents
-Intra-aortic balloon counterpulsation does not appear to provide benefit
-“Prasugrel or ticagrelor should be administered to patients at clinical high risk for stent thrombosis”
-Profile: Ulrich Sigwart